Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Gsk Plc (GSK.LN)

Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 72,432,724
  • Shares Outstanding, K 4,034,126
  • Annual Sales, $ 31,376 M
  • Annual Income, $ 2,575 M
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales 2.30
  • Price/Cash Flow 9.53
  • Price/Book 4.49
  • Price/Earnings ttm 13.50
  • Earnings Per Share ttm 1.33
  • Most Recent Earnings $0.49 on 10/29/25
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) 0.64 (3.56%)
  • Most Recent Dividend 0.160 on 11/13/25
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
1,774.000 +1.72%
on 01/20/26
1,909.730 -5.51%
on 01/07/26
-5.500 (-0.30%)
since 12/22/25
3-Month
1,592.000 +13.35%
on 10/24/25
1,909.730 -5.51%
on 01/07/26
+152.000 (+9.20%)
since 10/22/25
52-Week
1,242.500 +45.23%
on 04/09/25
1,909.730 -5.51%
on 01/07/26
+449.000 (+33.12%)
since 01/22/25

Most Recent Stories

More News
GSK Awards $2M in COiMMUNITY Initiative Grants to Help Close Vaccination Gaps, Commits $3M for 2026

Sixteen organizations, awarded funding in 2025, are taking innovative, local approaches to boosting vaccination in communities across the US Grant recipients’ projects aim to modernize...

GSK.LN : 1,804.500 (+0.95%)
GSK : 48.65 (+1.21%)
GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million

Grant funding awarded to support lupus-focused community programs across the United States

GSK.LN : 1,804.500 (+0.95%)
GSK : 48.65 (+1.21%)
Legal questions swirl around FDA's new expedited drug program, including who should sign off

A plan to slash Food and Drug Administration drug review times is raising alarms at the public health agency that's been rocked by recent layoffs and resignations

GSK.LN : 1,804.500 (+0.95%)
Exdensur (depemokimab) approved by US FDA for the treatment of severe asthma

Exdensur is the first and only ultra-long-acting biologic with twice-yearly dosing approved for patients with severe asthma with an eosinophilic phenotype Approval based...

GSK.LN : 1,804.500 (+0.95%)
GSK : 48.65 (+1.21%)
Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma

Significant unmet need for patients requires new and novel treatments 1 DREAMM-7 showed a 51% reduction in the risk of death and tripled median progression-free...

GSK.LN : 1,804.500 (+0.95%)
GSK : 48.65 (+1.21%)
New Local Data in GSK and IQVIA's Vaccine Track Supports Smarter Public Health Action at the Community Level

New analysis of metro-area data reveals wide variation in adult vaccination trends across the US and points to opportunities for local action Originally launched in 2022, Vaccine Track...

GSK.LN : 1,804.500 (+0.95%)
GSK : 48.65 (+1.21%)
Stocks Set to Open Higher as Bond Yields Fall, Trump’s Shutdown Talks in Focus

December S&P 500 E-Mini futures (ESZ25) are up +0.48%, and December Nasdaq 100 E-Mini futures (NQZ25) are up +0.63% this morning, pointing to a higher open on Wall Street as Treasury yields moved lower,...

PCAR : 123.56 (+0.24%)
APP : 521.94 (-1.99%)
MRUS : 90.00 (-7.14%)
CAG : 17.47 (+0.98%)
NKE : 65.46 (+0.08%)
NQZ25 : 25,132.79s (+0.42%)
CCL : 28.49 (+0.85%)
GSK.LN : 1,804.500 (+0.95%)
CRON : 2.68 (+2.68%)
COST : 976.17 (-0.68%)
GFS : 45.01 (-1.93%)
PAYX : 107.19 (unch)
GSK sponsors 2025 National Senior Games as part of Sideline RSV campaign to raise awareness of RSV in older adults

GSK and the National Senior Games team up to spotlight RSV risk, prevention, and the power of proactive health conversations National TV special “Redefining...

GSK.LN : 1,804.500 (+0.95%)
GSK : 48.65 (+1.21%)
US FDA Approves GSK’s SHINGRIX in a Prefilled Syringe Presentation

Prefilled syringe presentation offers a convenient administration option to healthcare professionals An estimated one million people develop shingles...

AGEN : 3.38 (-0.59%)
GSK.LN : 1,804.500 (+0.95%)
GSK : 48.65 (+1.21%)
Spero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study for Tebipenem HBr Stopped Early for Efficacy Following Review by Independent Data Monitoring Committee

SPRO : 2.45 (+3.81%)
GSK.LN : 1,804.500 (+0.95%)
GSK : 48.65 (+1.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 1,847.667
2nd Resistance Point 1,827.833
1st Resistance Point 1,816.167
Last Price 1,804.500
1st Support Level 1,784.667
2nd Support Level 1,764.833
3rd Support Level 1,753.167

See More

52-Week High 1,909.730
Last Price 1,804.500
Fibonacci 61.8% 1,654.848
Fibonacci 50% 1,576.115
Fibonacci 38.2% 1,497.382
52-Week Low 1,242.500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar